Lots of @KUcancercenter research on display this afternoon at #AACR26! Learn about a unique CAR -T therapy at Session PO.CTP01.02 - Phase I and Phase II Clinical Trials in Progress (Section 51) where our team members are presenting “Point-of-care manufacturing and early clinical evaluation of a tri-specific (CD19/20/22) CAR T-cell therapy for relapsed or refractory (R/R) B-cell malignancies” from 2-5pm PDT.